News Update on merger EC offered remedy proposal Staff November 20, 2023 Read the full announcement in PDF Attachment Update on merger EC offered remedy proposal Iframe sync Post navigation Previous: Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASHNext: Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission. More Stories Healthcare News Robotics Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed Staff December 19, 2025 News Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase Staff December 19, 2025 Cancer News Pharmaceutical IMG Saxony-Anhalt: 2026 in Sight – Saxony-Anhalt Sets the Pace for Future Industries Staff December 19, 2025
